This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216.
Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. BMT 1999; 23: 251–258.
Sirvent N, Reviron D, de Lamballerie X, Michel G . First report of Epstein–Barr virus lymphoproliferative disease after cord blood transplantation. Bone Marrow Transplant 2000; 25: 120–121.
Ohga S, Kanaya Y, Maki H, Takada H, Ohshima K, Kanda M et al. Epstein–Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond–Blackfan anemia. Bone Marrow Transplant 2000; 25: 209–212.
Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M . Detection of EBV DNA in the cord blood for a patient developing Epstein–Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. Bone Marrow Transplant 2001; 27: 761–765.
Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J et al. Low incidence of Epstein–Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395–399.
Shimasaki N, Mori T, Shimada H, Sugita M, Higuchi M, Mukai M et al. Epstein–Barr virus-associated posttransplant lymphoproliferative disorder after a cord blood stem cell transplantation presenting with pulmonary nodules. J Pediatr Hematol Oncol 2004; 26: 124–127.
Brunstein C, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein–Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.
van Esser JW, Niesters HG, van der Holt B, Meijer E, Osterhaus AD, Gratama JW et al. Prevention of Epstein–Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002; 99: 4364–4369.
Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M et al. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Am J Surg Pathol 2006; 30: 328–336.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reddiconto, G., Chiusolo, P., Fiorini, A. et al. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation. Leukemia 21, 2552–2554 (2007). https://doi.org/10.1038/sj.leu.2404818
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404818
This article is cited by
-
Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation
Annals of Hematology (2021)
-
EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
Bone Marrow Transplantation (2014)
-
Prospective Evaluation of Epstein–Barr Virus Reactivation After Stem Cell Transplantation: Association with Monoclonal Gammopathy
Journal of Clinical Immunology (2010)
-
EBV-associated post transplant lymphoproliferative disorder of the ‘loser’ graft cell origin following double unrelated umbilical cord blood transplantation
Bone Marrow Transplantation (2009)
-
Umbilical cord blood transplantation in adult myeloid leukemia
Bone Marrow Transplantation (2008)